Launch of the Report | Life Sciences in Brazil – The Impacts of Technology and Regulation
Description:
Deloitte, Biominas Brasil and BIO have gathered to conduct a pioneering research project, that aims to identify, from the leaders of companies in the life sciences sector, how the sector is positioning itself in Brazil in relation to technological evolution that impacts organizations, as well as a series of emerging regulatory issues.
Introduction and Presentation of the Report
- Eduardo Emrich, CEO, Biominas Brasil
- Enrico De Vettori, Consulting Partner, Life Sciences & Health Care Leader, Deloitte Brazil
- Justin Pine, Director of International Affairs, BIO
Discussion Panel
Speakers:
- Daniel Ferreira, Managing Director, Synova Licensing and Access
- Dirceu Barbano, Director, B2CD Consultoria Empresarial
- Eduardo Calderari, Market Access, Governmental Affairs & Commercial Head, Roche
- Elizabeth de Carvalhaes, President, Interfarma
- Marcela Silvino, Head, Sanofi Genzyme Brazil
- Marcello Scattolini, Access & Government Affairs Director, Boehringer Ingelheim
- Renato Porto, Director, ANVISA
